A r t i c l e s
Intestinal helminth infections represent one of the most prevalent chronic human infections worldwide 1 . Infection is associated with a polarized immune response, including the accumulation of type 2 helper T cells (T H 2 cells), eosinophils and basophils in tissues, more serum immunoglobulin E (IgE), hyperplasia of mucosal mast cells, alternative activation of tissue macrophages and epithelial and smooth-muscle alterations that change the physiological milieu of the host-mucosal interface where the parasites mediate their damage 2 . Similar alterations occur in allergic diseases, such as allergic asthma, although in this case the immune response is focused inappropriately on ubiquitous environmental allergens 3 . These host responses are frequently referred to as 'type 2 immunity' and are critically dependent on interleukin 4 (IL-4) and IL-13. The identification of an additional cell of the innate immune response involved in these types of host responses has added further complexity to the functional organization of cytokine-producing cells in type 2 immunity [4] [5] [6] [7] [8] .
T H 2 cells express IL-4 and IL-13, and the localization of these cytokines to sites of allergic immunity initiated efforts to link these cytokines themselves to mediating the diverse tissue manifestations associated with type 2 immunity. Indeed, whether administered exogenously, overexpressed or deleted, these two cytokines are necessary and sufficient to mediate most of the immunological and physiological aspects of type 2 immunity 2, [9] [10] [11] [12] [13] . IL-4 and IL-13 are encoded by adjacent genes that share many cis-acting and transactivating regulatory elements, and they transmit signals through a partially shared receptor and adaptor system 14, 15 . Despite that, epigenetic and functional studies have suggested unique and nonredundant roles for these cytokines during immunity in vivo, although the mechanisms that underlie these distinctions are not readily apparent on the basis of in vitro studies 2, [15] [16] [17] . Many innate and semi-invariant lymphocytes, including basophils, eosinophils, mast cells, innate helper type 2 cells (Ih2 cells) and natural killer T cells (NKT cells), can also be activated to produce IL-4 and IL-13 in vitro, but direct visualization of cytokine production by these cells in vivo has been incompletely characterized 4, 7, 18, 19 . One model that could explain the disparate in vitro and in vivo data is compartmentalized expression and divergent regulation of these two cytokines in vivo, a process that is difficult to examine with the tools available at present. Further understanding of the organization of type 2 immunity in secondary lymphoid tissues such as lymph nodes and spleen and in nonlymphoid tissues such as lung, liver, skin and small intestine will require improved methods for assessing cytokine production in vivo and in situ.
We generated a series of new strains of mice with genetically altered Il4 and Il13 loci that allow detection of cytokine expression by individual cells in vivo. Through the use of infections that induce robust type 2 host responses, we compared the production of IL-4 and IL-13 in selected lymphoid and tissue compartments. We found unexpected parsing of expression of these two closely related cytokines among cells of both the adaptive and innate immune responses. IL-13 production was largely confined to T H 2 cells and Ih2 cells in the lung and was associated with large amounts of cellular transcription factor GATA-3, which was necessary for sustaining the IL-13-producing phenotype. Conversely, follicular helper T cells (T FH cells) and basophils produced only IL-4 in vivo and did not have high expression of GATA-3.
A r t i c l e s RESULTS Compartmentalization of expression of IL-13 and IL-4 IL-4 and IL-13 share an overlapping spectrum of receptors, but studies with neutralizing reagents and mice deficient in individual cytokines and cytokine receptors have suggested a more prominent role for IL-13 in mediating the tissue responses that occur during infection with the helminth Nippostrongylus brasiliensis 2, 10 . Despite that information, precise knowledge about which cells produce IL-4 and IL-13 and their localization in vivo is lacking. We used a genetic approach to avoid caveats associated with restimulation of cells in vitro or ex vivo, such as the activation of all cytokine-competent cells, which can potentially obscure the physiological functions in situ. We used published IL-4 reporter mice that have a nonsignaling gene encoding human CD2 (huCD2) in place of the endogenous Il4 sequence at the Il4 start site (Il4 KN2 mice). Cells activated to produce IL-4 in Il4 KN2 mice express huCD2 on the cell membrane and provide an accurate report of IL-4-producing cells in vitro and in vivo 20, 21 . Homozygous Il4 KN2/KN2 mice are IL-4 deficient, whereas heterozygous Il4 KN2/+ mice are able to express IL-4 from the endogenous Il4 allele. Additionally, we generated IL-13 reporter mice with sequence encoding a fusion protein of enhanced yellow fluorescent protein (eYFP) and humanized Cre recombinase behind an internal ribosomal entry site (IRES) element introduced immediately downstream of the endogenous Il13 stop codon and upstream of the 3′ untranslated sequence (YetCre13). This construct leaves endogenous Il13 intact while establishing a bicistronic link with the sequence encoding the eYFP-Cre fusion protein 8 . Cells from Il13 YetCre/YetCre mice are able to make both endogenous IL-4 and IL-13. Crossing Il4 KN2 mice with Il13 YetCre mice allows simultaneous detection of IL-4-and IL-13-expressing cells ( Fig. 1a , Table 1 and Supplementary Fig. 1 ). The introduction of an additional ROSA26-loxP-flanked stop sequence-diphtheria toxin-α (ROSA-DTα) allele allowed in vivo elimination of cells that had activated Il13 expression, as expression of the eYFP-Cre fusion protein removed the loxPflanked stop sequence, which enabled toxin expression to ensue 8, 22 ( Fig. 1a , Table 1 and Supplementary Fig. 1 ).
To evaluate type 2 immunity in the various genetic strains of mice described above, we assessed the worm burden in the small intestine 9 d after infection with N. brasiliensis (Fig. 1a,b and Table 1 ). Consistent with published observations 2 , IL-4-deficient Il4 KN2/KN2 mice expelled worms normally. Immunity to N. brasiliensis was also intact in Il4 KN2/+ Il13 YetCre/+ mice and Il13 YetCre/YetCre mice ( Fig. 1b) . However, in Il4 KN2/+ Il13 YetCre/+ ROSA-DTα mice, worms were present at 9 d after infection in mice with one endogenous Il13 allele and one YetCre13 allele (Il13 YetCre/+ ) and were twice as prevalent in Il13 YetCre/YetCre ROSA-DTα mice, in which two YetCre13 alleles were present to drive Cre-mediated deletion (Fig. 1b) .
Although the absence of IL-4 in Il4 KN2/KN2 mice had no effect on the recruitment of eosinophils to tissues, deletion of IL-13-producing cells led to the attenuation of eosinophil accumulation in mice with one or two YetCre13 alleles paired with ROSA-DTα ( Fig. 1c) . Eosinophils did not produce IL-13 because they did not A r t i c l e s express eYFP in Il13 YetCre mice (as analyzed by flow cytometry), nor were these cells deleted from the blood, bone marrow or tissues of Il13 YetCre/YetCre ROSA-DTα mice ( Supplementary Fig. 2) . The deletion of IL-13-producing cells in Il13 YetCre/YetCre ROSA-DTα mice led to the concomitant ablation of IL-5, as these cytokines were coexpressed in this system ( Supplementary Fig. 3 ). It is likely that loss of both of these cytokines accounted for the lower eosinophilia in these mice.
In contrast to the effects on eosinophils, the number of basophils and CD4 + T cells in the lungs of Il13 YetCre/YetCre ROSA-DTα mice was unaffected by deletion of IL-13-expressing cells ( Fig. 1d) . Thus, IL-13-producing cells were required for sustaining tissue immunity to N. brasiliensis, and results obtained with these genetic variant strains confirmed published observations while confirming the utility of these reporter mice 2, 9, 11, 23 . IL-4 was required for IgE production, as Il4 KN2/KN2 mice were unable to mount an IgE response ( Fig. 1e) . However, deletion of IL-13-producing cells caused no deficit in IgE production, which suggested that IL-4-expressing T FH cells do not activate Il13 expression. To examine the effects of IL-13 expression on IL-4-mediated humoral responses, we immunized the various genetically marked mice with chicken ovalbumin conjugated to 4-hydroxy-3-nitrophenyl-acetyl (NP) in alum and assessed total IgG1 antibody to NP (anti-NP) and the affinity of the anti-NP response after 28 d, as described before 21 . As expected, the absence of IL-4 in Il4 KN2/KN2 mice and in mice with combined deficiency in IL-4 and IL-13 led to impaired expression of IgG1 protein and a diminished high-avidity anti-NP response ( Fig. 1f,g) . Although Il13 YetCre/YetCre ROSA-DTα mice, in which IL-13-expressing cells were deleted, had slightly less total NP-specific IgG1, the affinity maturation of anti-NP IgG1 was unaffected. As affinity maturation occurs in germinal centers, these findings were consistent with the absence of IL-13 expression in T FH cells.
In sum, the studies described above confirmed the utility of the Il4 KN2 and Il13 YetCre reporter strains in studying aspects of the expression of IL-13 and IL-4 during helminth infection. In addition, they suggested important roles for IL-4 in humoral responses but not tissue responses and supported the proposal of a fundamental role for IL-13 in tissue responses but not in high-affinity B cell responses. The deletion of IL-13-expressing cells had little effect on the activity of IL-4 expressing T FH cells in lymph nodes, which suggested that the expression patterns of these two cytokines are distinct. Thus, IL-4 and IL-13 serve distinct and nonredundant functions in type 2 immunity.
Visualization of the expression of IL-4 and IL-13 in vivo
We generated a second strain of IL-13 reporter mice by replacing the eYFP-Cre fusion protein used in the Il13 YetCre reporter with a nonsignaling human CD4 marker, which provided a cell surface membrane-anchored reporter with which to identify IL-13-expressing cells (Smart13 (surface marker for the transcript of Il13); Supplementary Fig. 4 ). We backcrossed these Il13 Smart mice to the BALB/c background and then crossed them with Il4 KN2 mice, which enabled simultaneous detection of the expression of both IL-4 and IL-13 at the single-cell level. After infecting Il4 KN2/+ Il13 Smart/+ mice with N. brasiliensis, we quantified IL-4-and IL-13-producing CD4 + T cells in the mediastinal lymph nodes and lungs directly after isolation ( Fig. 2a,b) . In the lymph nodes, approximately 8% of CD4 + T cells expressed IL-4 and IL-13, and of those, 98% expressed only IL-4 and not IL-13. In the lungs, approximately 15% of CD4 + T cells expressed IL-4 and IL-13 alone or together, and the number of IL-4-expressing CD4 + T cells and IL-13-expressing CD4 + T cells was approximately equal (Fig. 2b) . Thus, the ratio of IL-4producing cells to IL-13-producing cells was significantly greater in the lymph nodes than in the lungs ( Fig. 2c) . Of note, after restimulation in vitro, lung IL-5-producing CD4 + T cells mostly coexpressed IL-13 but not IL-4 ( Supplementary Fig. 3 ), which suggested that IL-13 and IL-5 share similar regulatory pathways that may be distinct from that of IL-4.
Immunohistochemical staining confirmed the higher ratio of IL-4producing cells to IL-13-producing cells in the lymph nodes than in the lungs ( Fig. 2d and Supplementary Fig. 5 ). As reported before 21 , IL-4producing huCD2 + cells were T FH cells confined to follicular and germinal center B cell-rich areas. The few IL-13-producing cells observed after acute infection with N. brasiliensis or more chronic infection with Leishmania major resided almost exclusively in the T cell zones and parafollicular areas of the lymph node ( Fig. 2d and Supplementary  Fig. 5 ). In contrast, IL-4-and IL-13-producing CD4 + T cells were intermingled in tissues at sites of allergic inflammation. Thus, IL-4and IL-13-expressing cells were used differently during immune responses. CD4 + T cells in B cell-rich areas of the lymph nodes did not express IL-13. Tissue T H 2 cells, however, expressed combinations of IL-4 and IL-13, with IL-5 production confined mainly to a subset of IL-13-expressing cells. To assess whether this divergent expression of IL-4 and IL-13 was a lung-specific phenomenon, we examined the intestines and mesenteric lymph nodes after infection with N. brasiliensis. Similar to results obtained for the lungs and lungdraining lymph nodes, CD4 + T cells isolated from the mesenteric lymph nodes produced substantial IL-4, whereas production of IL-13 was restricted to the small intestines ( Supplementary Fig. 6 ). These findings showed that IL-4 and IL-13 served distinct functions during allergic immunity in part due to their restricted expression patterns in lymphoid and nonlymphoid tissues.
T FH cells are distinct from T H 2 cells and do not produce IL-13
We next crossed each of the Il4 KN2 reporter mice and the Il13 Smart reporter mice to the 4get IL-4-reporter strain of mice (Il4 4get ), which allows transcription of bicistronic mRNA encoding IL-4, followed by an IRES and mRNA encoding enhanced green fluorescent protein (eGFP), and translation of both IL-4 and eGFP from the same mRNA. The progeny that result from these crosses allow marking of IL-4-or IL-13-producing cells among the larger subset of IL-4-and IL-13-competent cells 24 . At 8 d after infection with N. brasiliensis, approximately half of the 'competent' eGFP + CD4 + T cells in the mediastinal lymph nodes of Il4 KN2/4get mice expressed IL-4 in situ (huCD2 + ), and about 40% of those IL-4-producing cells had high expression of the T FH cell markers CD279 (PD-1) and CXCR5 (refs. 25-27; Fig. 3a,b) . In contrast, few of the eGFP + 'competent' CD4 + T cells expressed IL-13 in the lymph nodes and none of those IL-13-producing cells expressed T FH cell markers. Among the IL-13expressing CD4 + T cells in the lung, none had expression of CD279 (PD-1) and CXCR5 similar to that of lymph node IL-4producing T FH cells. Thus, IL-13-expressing T cells did not express T FH markers and did not localize to B cell areas. Furthermore, CD4 + T cells with markers characteristic of T FH cells were not present among the cytokine-expressing T H 2 cells in the lung. To more completely characterize the differences between cytokineexpressing T FH cells and T H 2 cells, we sorted populations of cytokinecompetent and cytokine-producing cells from the mediastinal lymph nodes and lungs of Il4 KN2/4get after infection with N. brasiliensis and analyzed IL-4 and IL-13 transcripts by quantitative PCR. Although IL-4-producing cells taken from the lymph nodes expressed less IL-4 and IL-13 mRNA than did their lung counterparts, they expressed more IL-21, a cytokine associated with T FH cells. Consistent with published reports on cytokine production by T FH cells during parasitic and viral infection 21, [27] [28] [29] , IL-4-producing cells from the lymph node had substantial expression of both IL-4 and IL-21 mRNA (Fig. 3c) , which suggested that T FH cells are poised to make IL-4 as well as IL-21 during a type 2 immune response. IL-4-producing cells from the lymph nodes also had much higher expression of Bcl-6, a key transcription factor in T FH development, than did IL-4-producing cells isolated from the lungs 26, 30, 31 . Conversely, lung IL-4-producing cells 'preferentially' expressed Blimp-1, a negative regulator of Bcl-6. Bcl-6 expression was inversely correlated not only with Blimp-1 transcripts but also with GATA-3 transcripts. Whether assessed by 'competence' (eGFP expression from the 4get allele) or 'expression' (huCD2 expression from the Il4 KN2 allele), IL-4-expressing lymph node CD4 + T cells had much lower GATA-3 mRNA expression and a greater abundance of Bcl-6 transcripts than did tissue IL-4-or IL-13-expressing T H 2 cells. We also found that inverse relationship in protein expression by intracellular staining and flow cytometry. Bcl-6 + cells were present only in lymph nodes, and Bcl-6 + CD4 + T cells were almost completely absent from lung tissue (Fig. 3d) . The GATA-3 hi cells did not express Bcl-6 in either tissue (Fig. 3d) . Furthermore, most IL-4-producing cells in the lymph nodes had high expression of Bcl-6, which confirmed their identity as T FH cells, but had little GATA-3, whereas IL-13-producing cells were uniformly GATA-3 hi and Bcl-6 − (Supplementary Fig. 7) . These results suggested that T FH cells and T H 2 cells have distinct and nonoverlapping profiles of transcription factor expression and probably use different transcription factors in different ways to achieve cytokine activation from the Il4 and Il13 loci.
Cytokine-producing T H 2 cells are GATA-3 hi
Although GATA-3 was originally linked to the production of IL-4 by T FH cells during helminth infection 29 , studies of mRNA expression during infection with lymphocytic choriomeningitis virus 27 have suggested that this might not be the case. To further explore the relationship between intracellular expression of GATA-3 and expression of IL-4 and IL-13 in T FH and T H 2 cells, we isolated T FH and T H 2 cells from Il4 KN2/+ Il13 Smart/+ dual reporter mice after infection with N. brasiliensis and assessed the expression of intracellular GATA-3 relative to in vivo cytokine expression at the single-cell level. In lymph nodes, the IL-4producing CD4 + T cells were predominantly GATA-3 lo . Only 20% of the total IL-4-producing cells had high expression of intracellular GATA-3 in the lymph nodes ( Fig. 4) . However, this was not the case in the lungs, in which over 70% of IL-4 production was associated with a GATA-3 hi population. We also observed this difference in the expression of GATA-3 in lymphoid and nonlymphoid tissues among gut and mesenteric lymph node-resident IL-4-producing CD4 + T cells ( Supplementary  Fig. 8) . The relationship between IL-13 production and GATA-3 was distinctly different because over 90% of the IL-13-producing cells were GATA-3 hi regardless of whether the CD4 + T cells were isolated from the lymph nodes (in which there were very few cells) or the lungs. Thus, IL-4 expression by T FH cells was associated with low expression of GATA-3, whereas expression of IL-13 by T H 2 cells was associated with large amounts of intracellular GATA-3 (Figs. 3c,d and 4) independently of the tissue origin of the IL-13-expressing CD4 + T cells.
IL-4 and IL-13 are not required for high GATA-3 expression Signals from IL-4 and IL-13 can directly drive GATA-3 expression, leading to autoactivation and a feed-forward loop that sustains the A r t i c l e s cells in a GATA-3 hi cytokine-expressing state 32 . To investigate whether cytokine signaling was required for higher GATA-3 expression and IL-13 production, we generated Il4 KN2/+ Il13 Smart/+ double-reporter mice on a background deficient in the transcription factor STAT6. There was a lower frequency of GATA-3 hi CD4 + T cells in both the lymph nodes and the lungs (Fig. 5a) , and we noted this effect in both the IL-4expressing CD4 + T cells and IL-13-expressing CD4 + T cells of the dualreporter mice (Fig. 5b) . We obtained similar results with Il4 KN2/4get mice and Il4 4get/+ Il13 Smart/+ mice deficient in IL-4 receptor-α expression ( Supplementary Fig. 9 ). Of note, although we observed a lower frequency of IL-4-producing CD4 + T cells in the lymph nodes and lungs of Il4 KN2/+ Il13 Smart/+ mice than in those of wild-type mice, there was no difference in the number of total IL-4-producing cells at 8 d after infection with N. brasiliensis (Fig. 5c) . Similarly, we found no significant effect of STAT6 deficiency on the frequency or number of IL-13-producing CD4 + T cells in the lungs of Il4 KN2/+ Il13 Smart/+ mice (Fig. 5c) . Furthermore, when we reconstituted sublethally irradiated wild-type mice and mice deficient in IL-4 and IL-13 with either congenic IL-4-IL-13-deficient or wild-type naive CD4 + T cells, and then infected the mice with N. brasiliensis, we observed similar proportions of GATA-3 hi cells among activated (ICOS + ) donor T cells ( Supplementary Fig. 10 ), which suggested that IL-4 and IL-13 derived from T cells or from host cells were not necessary to drive GATA-3 expression to large amounts. Thus, high GATA-3 expression associated with tissue cytokine expression, particularly IL-13, was optimized by the presence of signaling from IL-4 and IL-13, but neither cytokine was required for the development of T H 2 cells into a GATA-3 hi cytokineexpressing state in vivo. IL-4 production in lymphoid tissues occurred independently of both STAT6 and higher GATA-3 expression.
IL-13 is associated with high GATA-3 expression in Ih2 cells
The use of 4get mice has facilitated the recognition of many cell types competent to produce IL-4 (as assessed by eGFP expression), including not only T H 2 cells and T FH cells but also natural NKT cells, mast cells, basophils, eosinophils and Ih2 cells, all of which express eGFP constitutively in 4get mice because of the permissive A r t i c l e s translational features of the IRES 4, 8, 18, 19, 33, 34 . To assess the contributions of these various cells to tissue responses in type 2 immunity, we assessed IL-4-expressing eGFP + huCD2 + cells in Il4 KN2/4get mice and IL-13-expressing eGFP + huCD4 + cells in Il4 4get/+ Il13 Smart/+ mice in the lungs 9 d after infecting the mice with N. brasiliensis (Fig. 6a,b) . At this time point, CD4 + T cells and basophils represented the only IL-4-expressing cells in the lung, and CD4 + T cells and Ih2 cells were the only IL-13-expressing cells. We were unable to directly visualize IL-13 expression in other cytokine-competent cell populations, including eosinophils, NKT cells and basophils, which was consistent with the lack of an immune phenotype after deletion of these cell types during primary infection with this helminth 23, [35] [36] [37] [38] . Of note, invariant NKT cells, although present in the lung at this time, made little IL-13 ( Supplementary Fig. 11 ). Thus, although each of these cells was able to express IL-4 and IL-13 after stimulation in vitro, this study showed that expression in vivo was regulated in a much more restricted way than previously anticipated.
CD4 + T cells were the only cells that produced both IL-4 and IL-13 in the lungs (Fig. 6a,b) . We confirmed the restricted pattern of IL-13 expression among Ih2 and CD4 + T cells by infecting Il13 YetCre mice with N. brasiliensis. As observed for infected Il4 4get/+ Il13 Smart/+ mice, CD4 + T cells were the predominant IL-13-producing subset. However, Ih2 cells, marked as lineage negative (Lin − ; lacking markers for common lineage determinants for T cells, B cells, NK cells, dendritic cells or other myeloid cells 7 ) and negative for the sialoadhesin CD169 (Siglec-F), CD131 (common β-chain of the receptor for IL-3) and the integrin 
A r t i c l e s CD49b (DX5) and positive for ICOS, also produced IL-13 at 9 d after infection (Fig. 6c,d) . Ih2 cells were substantially deleted in Il13 YetCre ROSA-DTα mice (Fig. 6e) , which indicated that these cells were a relevant population of IL-13-expressing cells in this infectious model. We also observed IL-13 expression restricted to T H 2 cells and Ih2 cells in the small intestines of N. brasiliensis-infected IL4 4get/+ Il13 Smart/+ mice (Supplementary Fig. 6) .
IL-4 expression by basophils and IL-13 expression by Ih2 cells resembled the distinctive cytokine patterns of T FH cells and T H 2 cells,
which expressed IL-4 and IL-13, respectively, in a manner associated with distinct amounts of GATA-3. Lin − ICOS + Ih2 cells constituted the only non-T cell GATA-3 hi population in the lung (Fig. 7a) . In contrast, basophils, assessed by expression of CD49b (DX5), were the only IL-4producing innate cells in the lungs at 9 d after infection with N. brasiliensis and did not express GATA-3. Intracellular GATA-3 staining in Il4 KN2/4get and IL4 4get/+ Il13 Smart/+ reporter mice showed that GATA-3 hi T H 2 cells expressed both IL-4 and IL-13 in vivo, whereas GATA-3 hi Ih2 cells or GATA-3 lo basophils expressed only IL-13 or IL-4, respectively (Fig. 7b) . Thus, as in T cells, IL-13 was expressed only in GATA-3 hi innate cells, which during infection with N. brasiliensis were Ih2 cells.
As with T H 2 cells, the total number of ICOS hi GATA-3 hi Ih2 cells and the frequency of IL-13-producing Ih2 cells in the lung were not b a Il13 YetCre/+ Gata3 / significantly lower in the absence of STAT6 (Fig. 7c,d) . However, the lungs of STAT6-deficient Il4 KN2/+ Il13 Smart/+ mice had 50% as many total IL-13-producing Ih2 cells as the lungs of wild-type Il4 KN2/+ Il13 Smart/+ mice had on day 8 after infection with N. brasiliensis. Over 95% of the Ih2 cells that produced IL-13 also had high intracellular expression of GATA-3 (Fig. 7e) . We obtained similar results with IL-4 receptor-α-deficient mice (Supplementary Fig. 9 ). Thus, as in T H 2 cells, GATA-3 expression and IL-13 production occurred independently of STAT6, but optimal numbers of Ih2 cells required STAT6dependent signals, which suggested a role for signaling via the IL-4 receptor in their maintenance or survival.
IL-13 production and worm clearance require GATA-3
To determine whether GATA-3 is required for IL-13 production, we crossed Il13 YetCre mice with mice with loxP-flanked Gata3 alleles (Gata3 fl/fl ) to generate mice in which GATA-3 would be deleted only in IL-13-producing cells 39 . At 9 d after infection with N. brasiliensis, IL-13 production, as assessed by eYFP expression from the Il13 YetCre allele, was significantly lower in CD4 + T cells and was absent from Ih2 cells isolated from the lungs of Il13 YetCre/+ Gata3 fl/fl mice relative to its production in control Il13 YetCre/+ Gata3 fl/+ mice (Fig. 8a,b) . Ablation of GATA-3 in IL-13-producing cells resulted in a phenocopy of our results with Il13 YetCre ROSA-DTα mice, in that both the recruitment of eosinophils to the lung and worm clearance were compromised (Fig. 8b,c) . IgE production was unaffected in these mice (Fig. 8c) , which confirmed the proposal that the T FH cell-IL-4 arm of allergic immunity, which supports antibody production, is distinct from the T H 2-Ih2 cell-driven IL-13 arm responsible for the peripheral manifestations of type 2 immune responses, including the recruitment of eosinophils to tissues and worm expulsion.
DISCUSSION
Here we used new lines of mice to expose an unexpected partitioning of IL-4 and IL-13, cytokines linked to the mediation of allergic immunity and to helminths, among tissues and cell types. T FH cells expressed IL-4, whereas T H 2 cells expressed a spectrum of either IL-4 or IL-13, or both IL-4 and IL-13. In confirmation of published studies 8, 11, 21, 23 , deletion of IL-4 led to profound deficiencies in humoral immunity with minimal effects on tissue responses, whereas deletion of IL-13-expressing cells led to profound effects on tissue immunity with minimal effects on humoral responses. Among cells of the innate immune system, basophils expressed IL-4 but not IL-13, whereas Ih2 cells expressed IL-13 but not IL-4. We extended published observations demonstrating that T FH cells constitute the most prevalent IL-4-producing cells in the lymph nodes during allergic immunity 21 by showing that these cells did not activate Il13 expression, as assessed by direct marker analysis and lineage-mediated deletion. Thus, despite having a locus 'competent' for production of the linked type 2 cytokines, T FH cells and T H 2 cells produced these cytokines differently in vivo.
The mechanisms that prevent the concordant activation of both Il4 and Il13 remain of interest. Although small amounts of GATA-3 are required in naive CD4 + T cells, chromatin modifications and the accessibility of GATA-3 to select sites in the Il4 and Il13 loci have an important regulatory role in the different expression of IL-4 and IL- 13 (refs. 40,41) . Our in vivo results confirmed those findings by showing an obligatory role for GATA-3 in IL-13 production by canonical T H 2 cells, but they also suggested that the regulation of IL-4 and IL-13 in CD4 + T cells in vivo is more complicated, as T FH cells did not require large amounts of GATA-3 for IL-4 production and did not express IL-13. We considered the possibility that IL-4 and/or IL-13 from cells of the innate immune system in the periphery might contribute to the terminal differentiation of T H 2 cells by directly upregulating GATA-3 to thresholds needed to facilitate the expression of Il13 (and Il5) by binding to the respective promoters of these genes 15, 32 . Although the absence of STAT6 or IL-4 receptor-α had some effect on the ultimate number of GATA-3 hi T H 2 effector cells that developed in tissues, the ability of CD4 + T cells to achieve a GATA-3 hi IL-13-producing phenotype was not lost, a finding consistent with published studies 42 . Further studies are needed to explore the pathways that enable STAT6independent differentiation of T H 2 cells in vivo.
We speculate that large amounts of Bcl-6 in T FH cells restrict GATA-3 to concentrations insufficient to activate Il13 (and probably Il5). Although Bcl-6 is a direct transcriptional repressor for many genes, it might suppress GATA-3 at a post-transcriptional level, perhaps through suppression mediated by microRNA 30, 43, 44 . Because Bcl-6 overexpression can induce a T FH phenotype 26 , we are tempted to speculate that decay of Bcl-6 or expression of Blimp-1 in T cells after they leave secondary lymphoid tissues is a prerequisite for relieving repression of the genetic programs, such as homing and extended cytokine expression, necessary for the completion of T H 2 differentiation in the periphery 21, 25 . Alternatively, Bcl-6 may be needed to sustain the expression of cytokines and chemokines required for efficient interactions with B cells. In this way, the development of effector T H 2 cells is delayed until the cells enter peripheral tissues, where the local cytokine milieu can be sensed, thus enabling plasticity in the response.
The use of a Cre fusion protein allowed us to demonstrate that deletion of IL-13-producing cells was sufficient to block peripheral manifestations of type 2 immunity, including helminth expulsion and the infiltration of eosinophils into tissues. The finding that deletion of these cells resulted in a phenocopy of the loss of IL-13 suggested that the main role of these cells in type 2 immunity is the tissue distribution of IL-13, at least as assessed in this model 2, 11 . Furthermore, we found that specific deletion of GATA-3 in the IL-13-producing cells was sufficient to inhibit the peripheral manifestations of type 2 immunity. As assessed by direct visualization in vivo, only T H 2 cells and Ih2 cells expressed IL-13 in tissues during this infection, which suggested that either or both of these cells is (are) required for optimal tissue immunity 6, 8, 23 . The role for IL-13 from Ih2 cells may be of particular importance in considering T cell-independent responses, perhaps during challenges with less noxious antigens, such as allergens, or during tissue repair.
It is important to consider some of the caveats associated with the introduction of markers at the cytokine genes. We used knockin approaches that left endogenous expression intact from a locus regulated by the endogenous cis-acting elements. Regardless of such similar regulation, the introduction of exogenous genetic material unavoidably alters genomic distances and perhaps affects the speed of transcription or modify long-distance interactions that are dependent on precise spacing elements. To the best of our ability, we have documented that these markers acted similarly to the endogenous genes in wild-type genomes in all aspects, with the caveat that the half-lives of the markers, particularly membrane proteins such as CD2 and CD4, are distinct from the half-lives of the secreted cytokine proteins.
Given our observations, therapeutic targeting of IL-4 or IL-13 would be predicted to have very different effects depending on whether the intended targets reflect aspects of humoral or cellular responses. Together our studies have shown previously unappreciated regulation of these duplicated cytokines, as suggested by the differences between IL-4-and IL-13-expressing cells in dependence on and expression of GATA-3. This should provide fruitful opportunities for further understanding of the nuances that underpin gene regulation in cells of the immune system.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
